Transaction · 0001193125-26-217593

Li Nan (Ln)

Li Nan (LN), DIR, reported a transaction classified as unknown at Odyssey Therapeutics, Inc. involving 16611626.000000 shares. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code CDIR
ODTXOdyssey Therapeutics, Inc.
Trade date
May 11, 2026
Filing date
May 12, 2026
View on SEC Insider profile
Disclosed valueUnknownShares × reported price
Shares traded16.6MPrice unknown
Holdings after0Indirect · See footnote
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

ODTX price since this filing

Daily closing prices, with the filing date and available return windows
ODTX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
unknown
Code C
Identifier
0001193125-26-217593
Series D Convertible Preferred Stock
Transaction date
May 11, 2026
Filed May 12, 2026, 12:30 AM · 1d delay
Shares
16,611,626 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
0 sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction
Filing-only score

-20 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration.…

  2. F2

    These securities are held by Dimension Capital II, L.P. Dimension Capital II, L.P. is controlled by Dimension Capital II GP, L.P., its general partner, which is itself controlled by Dimension Capital…

  3. F3

    Reflects shares purchased in the Issuer's initial public offering.

  4. F4

    Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering.

Original filing · 0001193125-26-217593
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ODTX